Medicare IVIG Access Enhancement Act
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 14, 2021
Referred to the Subcommittee on Health.
Jun 11, 2021
Referred to the Subcommittee on Health.
Jun 11, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 11, 2021
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Medicare IVIG Access Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
What's happening now
Referred to the Subcommittee on Health.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
4
Cite this page
U.S. Congress. (2026). H.R. 3808: Medicare IVIG Access Enhancement Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-3808/
"H.R. 3808: Medicare IVIG Access Enhancement Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-3808/.
H.R. 3808, 117th Cong. (2026), https://openamerica.io/bill/117-HR-3808/.
[H.R. 3808: Medicare IVIG Access Enhancement Act](https://openamerica.io/bill/117-HR-3808/)